Skip to content

Tag Archives: highly-active

Prevention of mother-to-child transmission of HIV among pregnant women using injecting drugs in Ukraine, 2000-2010

Friday, August 5, 2011

Abstract Aims:  To compare clinical status, mother-to-child transmission (MTCT) rates, use of prevention of (PMTCT) interventions and pregnancy outcomes between HIV-infected injecting drug users (IDUs) and non-IDUs. Design and setting:  Prospective cohort study conducted in 7 HIV/AIDS Centres in Ukraine, 2000-2010. Participants:  Pregnant HIV-infected women, identified before/during pregnancy or intrapartum, and their live-born infants (n = 6200); 1028 women followed post-partum

Filed in Evidence Base | Also tagged , , , , , , , , , , | Comments (0)

Alcohol use and non-adherence to antiretroviral therapy in HIV-infected patients in West Africa

Monday, June 7, 2010

Aim To investigate the association between alcohol use and adherence to highly active antiretroviral treatment (HAART) among human immunodeficiency virus (HIV)-infected patients in subSaharan Africa.Design and setting Cross-sectional survey conducted in eight adult HIV treatment centres from Benin, Côte d’Ivoire and Mali.Participants and measurements During a 4-week period, health workers administered the Alcohol Use Disorders Identification Test to HAART-treated patients and assessed treatment adherence using the AIDS Clinical Trials Group follow-up questionnaire.Findings A total of 2920 patients were enrolled with a median age of 38 years [interquartile range (IQR) 32[ndash]45 years] and a median duration on HAART of 3 years (IQR 1[ndash]4 years). Overall, 91.8% of patients were identified as adherent to HAART.

Filed in Evidence Base | Also tagged , , , , , , , , , , | Comments (0)